Details for Patent: 12,403,120
✉ Email this page to a colleague
Which drugs does patent 12,403,120 protect, and when does it expire?
Patent 12,403,120 protects LASIX ONYU and is included in one NDA.
This patent has three patent family members in three countries.
Summary for Patent: 12,403,120
| Title: | Pharmaceutical compositions of furosemide and uses thereof |
| Abstract: | A pharmaceutical composition and a method of administering the pharmaceutical composition to a patient suffering from edema, heart failure, kidney or liver disease or having symptoms thereof is disclosed. The pharmaceutical composition includes furosemide, or a pharmaceutically acceptable salt, hydrate or ester thereof and tris(hydroxymethyl)aminomethane. The furosemide is present in the pharmaceutical composition at a concentration from about 10 mg/mL to about 30 mg/mL and the tris(hydroxymethyl)aminomethane is present at a concentration of less than or equal to 40 mM. The pH value of the pharmaceutical composition is maintained between about 8.0 and about 8.5 for parenteral administration. |
| Inventor(s): | Pieter Muntendam |
| Assignee: | SQ Innovation AG |
| Application Number: | US17/311,634 |
|
Patent Claim Types: see list of patent claims | Use; Composition; |
Drugs Protected by US Patent 12,403,120
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sq Innovation | LASIX ONYU | furosemide | SOLUTION;SUBCUTANEOUS | 217294-001 | Oct 7, 2025 | RX | Yes | Yes | 12,403,120 | ⤷ Start Trial | Y | TREATMENT OF EDEMA IN ADULT PATIENTS WITH CHRONIC HEART FAILURE | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 12,403,120
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| European Patent Office | 3893843 | ⤷ Start Trial | |||
| Spain | 3041602 | ⤷ Start Trial | |||
| World Intellectual Property Organization (WIPO) | 2020120482 | ⤷ Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
